Journal of Clinical Psychiatry Issue 62(11)

Dopamine System Stabilizers, Aripiprazole, and the Next Generation of Antipsychotics, Part 1: "Goldilocks" Actions at Dopamine Receptors

Leptin Concentrations Are Increased in Subjects Treated With Clozapine or Conventional Antipsychotics

Olanzapine Treatment of Female Borderline Personality Disorder Patients: A Double-Blind, Placebo-Controlled Pilot Study

Injections of Depot Antipsychotic Medications in Patients Suffering From Schizophrenia: Do They Hurt?

Paroxetine in the Treatment of Chronic Posttraumatic Stress Disorder: Results of a Placebo-Controlled, Flexible-Dosage Trial

Response and Remission Rates in Different Subpopulations With Major Depressive Disorder Administered Venlafaxine, Selective Serotonin Reuptake Inhibitors, or Placebo

A Double-Blind, Placebo-Controlled Trial of Extract of Ginkgo biloba Added to Haloperidol in Treatment-Resistant Patients With Schizophrenia

Comorbidity of Axis I Disorders in Patients With Traumatic Grief

Pattern of Symptom Improvement Following Treatment With Venlafaxine XR in Patients With Generalized Anxiety Disorder

Effect of Risperidone on Behavioral and Psychological Symptoms and Cognitive Function in Dementia

Antiaggressive Effect of Quetiapine in a Patient With Schizoaffective Disorder

Body Weight Gain, Insulin, and Leptin in Olanzapine-Treated Patients

Effective Treatments for PTSD: Practice Guidelines From the International Society for Traumatic Stress Studies

Trauma and Stress: Diagnosis and Treatment.[CME]